INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q2 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $280,000 | -80.4% | 26,700 | -70.2% | 0.01% | -64.0% |
Q1 2016 | $1,431,000 | +46.8% | 89,461 | +162.5% | 0.02% | +150.0% |
Q4 2015 | $975,000 | +55.0% | 34,081 | +128.5% | 0.01% | +150.0% |
Q4 2014 | $629,000 | +109.7% | 14,916 | +93.3% | 0.00% | +300.0% |
Q3 2014 | $300,000 | – | 7,716 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 8,912,072 | $142,504,000 | 2.66% |
Antipodean Advisors LLC | 342,294 | $5,473,000 | 2.48% |
JW Asset Management, LLC | 221,538 | $3,542,000 | 2.31% |
Parametrica Management Ltd | 33,562 | $537,000 | 1.92% |
12 West Capital Management LP | 623,791 | $9,974,000 | 1.39% |
Folger Hill Asset Management LP | 1,418,138 | $22,676,000 | 1.27% |
Bellevue Group AG | 281,000 | $4,493,000 | 0.82% |
Plymouth Lane Capital Management, LLC | 55,300 | $884,000 | 0.78% |
Orbimed Advisors | 4,557,740 | $72,878,000 | 0.77% |
DIALECTIC CAPITAL MANAGEMENT, LP | 79,550 | $1,272,000 | 0.60% |